Assignee
QURIENT CO LTD
KR·8 granted patents·7 pending applications·3 citations·filing 2014–2023
Top patents by PatentIndex Score
15 records- 0170US11858937B2Substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitorsQURIENT CO LTD·Filed 2019·Granted Jan 2, 2024·1 cites·47 claims
- 0269US9855243B2Topical anti-inflammatory pharmaceutical composition with zileuton cream formulationQURIENT CO LTD·Filed 2016·Granted Jan 2, 2018·1 cites·11 claims
- 0362US2026041693A1Combination therapy of cdk7 inhibitors with other anti-cancer therapiesQURIENT CO LTD·Filed 2023·Application pending·0 cites
- 0460US2025205242A1Cdk7 inhibitors for antiviral treatmentQURIENT CO LTD·Filed 2023·Application pending·0 cites
- 0558US9655841B2Topical anti-inflammatory pharmaceutical composition with zileuton cream formulationQURIENT CO LTD·Filed 2014·Granted May 23, 2017·1 cites·7 claims
- 0656US12582598B2Topical anti-inflammatory pharmaceutical composition comprising ZileutonQURIENT CO LTD·Filed 2019·Granted Mar 24, 2026·0 cites·18 claims
- 0754US2024343732A1Compounds for degradation of cyclin-dependent kinase 7(cdk7)QURIENT CO LTD·Filed 2022·Application pending·0 cites
- 0853US12410165B2Different forms of 6-chloro-2-ethyl-N-(4-(4-(4-(trifluoromethoxy)phenyl)piperidine-1-yl)benzyl)imidazo[1,2-a]pyridine-3-carboxamideQURIENT CO LTD·Filed 2019·Granted Sep 9, 2025·0 cites·16 claims
- 0953US2025263413A1Compounds having cyclin-dependent kinase(cdk)-inhibitory functionQURIENT CO LTD·Filed 2021·Application pending·0 cites
- 1051US2025188058A1New forms of n-(5-((6,7-dimethoxyquinolin-4-yl)oxy)pyridin-2-yl)-1-propyl-4-(2,2,2-trifluoroethoxy)-1h-pyrazole-3-carboxamide hydrochlorideQURIENT CO LTD·Filed 2022·Application pending·0 cites
- 1149US2018092877A1Topical anti-inflammatory pharmaceutical composition with zileuton cream formulationQURIENT CO LTD·Filed 2017·Application pending·0 cites
- 1245US2023055208A1A pharmaceutical oral dosage form of q203QURIENT CO LTD·Filed 2020·Application pending·0 cites
- 1340US12162858B2Quinoline derivatives as inhibitors of AXL/MER RTK and CSF1RQURIENT CO LTD·Filed 2019·Granted Dec 10, 2024·0 cites·23 claims
- 1439US11945822B2Pyrazolo-triazine and/or pyrazolo-pxrimidine derivatives as selective inhibitor of cyclin dependent kinaseQURIENT CO LTD·Filed 2019·Granted Apr 2, 2024·0 cites·20 claims
- 1529US10934274B2Quinoline derivatives as TAM RTK inhibitorsQURIENT CO LTD·Filed 2016·Granted Mar 2, 2021·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →